- Home
- SRPT vs ARR Comparison
SRPT vs ARR Comparison
Compare SRPT & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SRPT | ARR |
|---|---|---|
| Founded | 1980 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.4B | 2.1B |
| IPO Year | 1997 | N/A |
Fundamental Metrics
Financial Performance| Metric | SRPT | ARR |
|---|---|---|
| Price | $20.46 | $17.47 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 28 | 4 |
| Target Price | ★ $25.76 | $18.17 |
| AVG Volume (30 Days) | 3.1M | ★ 4.0M |
| Earning Date | 02-25-2026 | 02-12-2026 |
| Dividend Yield | N/A | ★ 15.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.65 |
| Revenue | ★ $2,413,715,000.00 | $116,798,000.00 |
| Revenue This Year | $14.46 | $296.22 |
| Revenue Next Year | N/A | $99.47 |
| P/E Ratio | ★ N/A | $28.24 |
| Revenue Growth | ★ 47.15 | N/A |
| 52 Week Low | $10.42 | $13.18 |
| 52 Week High | $120.05 | $19.31 |
Technical Indicators
Market Signals| Indicator | SRPT | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 43.86 | 37.41 |
| Support Level | $20.10 | $18.09 |
| Resistance Level | $24.68 | $18.66 |
| Average True Range (ATR) | 1.50 | 0.41 |
| MACD | -0.15 | -0.14 |
| Stochastic Oscillator | 6.99 | 0.00 |
Price Performance
Historical ComparisonAbout SRPT Sarepta Therapeutics Inc. (DE)
Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.